NDC US FDA Drug Registration and Listing System – Overview

https://www.xproamerica.com/sales-lead/index.phpThe NDC US FDA Drug Registration and Listing System is a core regulatory requirement for drug products introduced into the United States market. This system allows the U.S. Food and Drug Administration to identify, track, and monitor drugs that are manufactured, repackaged, relabeled, or distributed commercially. Compliance with US FDA drug establishment registration and listing rules is mandatory for both domestic and foreign drug companies.

The National Drug Code (NDC) is a unique 10- or 11-digit numeric identifier assigned to each drug product after successful listing. The code is divided into three segments that represent the labeler, product formulation, and package configuration. To obtain an NDC, a company must first complete US FDA Drug Establishment Registration, followed by submission of drug listing information through the US FDA electronic system.

How the US FDA NDC Listing Process Works

Each drug establishment must renew its registration annually with the US FDA. After registration, detailed drug listing data is submitted, including proprietary and non-proprietary drug names, dosage form, strength, route of administration, labeling information, and packaging details. Once reviewed, the US FDA assigns the NDC number, which must be displayed on drug labels and related documentation.

It is important to understand that NDC assignment does not mean US FDA approval. The registration and listing system is designed for regulatory identification and post-market oversight, supporting activities such as inspections, recalls, and safety monitoring.

Importance of Accurate NDC Registration

Incorrect, outdated, or missing NDC listings may result in regulatory actions such as import refusal, warning letters, or product removal from the US market. Accurate NDC data is also essential for wholesalers, pharmacies, and healthcare systems that rely on this information for distribution and reimbursement.

Organizations such as XPRO America, a recognized US FDA Consultancy, regularly engage in regulatory discussions and compliance-related inquiries related to US FDA drug registration and listing requirements. For general regulatory questions or clarification on US FDA processes, correspondence may be directed to support@xproamerica.com.